An implant education & consultation resource · Consultations at affiliated offices in Huntington Beach, Marina del Rey & DowneyBeachside · (714) 842-6151
Candidacy

Osteoporosis Medications and Dental Implants: What to Know First

Taking a bisphosphonate or denosumab for osteoporosis does not automatically rule out implants. What the jaw risk is, how it differs by dose, and why the medication is not yours to stop.

By DICHB editorial teamPrepared from established dental references · clinical review by Dr. Sameer Aljanedi pendingPublished

A patient and dentist reviewing a dental X-ray together on a monitor
On this page

Taking a bisphosphonate or denosumab for osteoporosis does not automatically rule out dental implants. The American Dental Association states that antiresorptive therapy does not appear to be a contraindication for dental implant placement, while adding that larger and longer-term studies are still needed. The concern behind the question is a rare jaw condition called medication-related osteonecrosis of the jaw, and how much it applies to you depends on which drug you take, at what dose, and why.

Do not stop or change a prescribed medication on your own. That decision belongs to the physician who prescribes it, working with the dentist who would do the surgery.

Cleveland Clinic describes osteonecrosis of the jaw as a rare but serious condition that causes bone cells in the jawbone to die. The most obvious sign, it says, is an area of exposed jawbone that does not heal, and exposed bone that persists for more than eight weeks indicates the condition. Other signs it lists are jaw pain, loose teeth, mouth sores, swollen gums and signs of infection.

When the condition is linked to a drug it is called medication-related osteonecrosis of the jaw, or MRONJ. The ADA names bisphosphonates, denosumab and romosozumab as drugs associated with it. The American Association of Oral and Maxillofacial Surgeons (AAOMS) says the exact cause is not fully understood.

It matters for implants because of when it tends to appear. The ADA notes that osteonecrosis of the jaw typically occurs following tooth extractions or other surgery involving the teeth and the bone around them. Cleveland Clinic includes getting a dental implant or a bone graft among the procedures it tends to follow.

Osteoporosis doses and cancer doses carry different riskLink to this section: Osteoporosis doses and cancer doses carry different risk

The ADA gives denosumab as an example. For osteoporosis it is a 60-mg injection every 6 months. For cancer-related uses it is 120 mg every 4 weeks. The ADA lists alendronate, ibandronate, risedronate and zoledronic acid as bisphosphonates approved for osteoporosis, and notes that some are also approved in more intensive, higher-dose regimens for other conditions.

The reported risk follows the dose. The ADA states that the incidence of MRONJ is generally considered to be between 1% and 10% of patients taking IV bisphosphonates for cancer that has spread to bone, and between 0.001% and 0.01% in patients taking oral bisphosphonates for osteoporosis. It also cites an expert panel that put the highest reliable estimate of prevalence at approximately 0.10% in patients on osteoporosis doses and regimens.

Cleveland Clinic makes the same point: the condition mostly happens in people taking high doses of cancer medicines, and the low-dose forms used for osteoporosis do not pose the same risks. AAOMS likewise says the risk is lower for osteoporosis than for cancer treatment.

The drug is one factor among several. The risk factors the ADA lists include:

  • Age older than 65
  • Periodontitis, the advanced form of gum disease
  • Poor oral hygiene
  • Surgery on the teeth and jawbone, including tooth extraction
  • High-dose or prolonged use of these drugs, which it gives as more than 2 years
  • Smoking
  • Corticosteroid therapy or chemotherapy
  • Denture wearing
  • Diabetes

Implants and gum disease, smoking and implant healing and diabetes and implant candidacy each cover one of these.

Why stopping the medication yourself is the wrong moveLink to this section: Why stopping the medication yourself is the wrong move

The ADA states that there is insufficient evidence to recommend a "holiday" from antiresorptive therapy for osteoporosis, or waiting periods before dental treatment, as a way of preventing MRONJ. It adds that discontinuing bisphosphonate therapy may not eliminate the risk, and that discontinuation may have a negative impact on the treatment of low bone mass.

The other side of the scale is the fracture the drug is there to prevent. The expert panel the ADA cites concluded that the potential harm from osteoporosis-related fractures is considerable, and that treatment with these drugs outweighs the low risk of MRONJ in patients with osteoporosis.

Any change to timing or dosing is therefore a medical decision, made by the prescriber and the dentist together.

What to tell the dentistLink to this section: What to tell the dentist

Cleveland Clinic says that if you are already taking one of these medicines, it is very important that your dentist or oral surgeon knows. Bring the details in writing:

  • The name of the drug, the dose, and whether it is a pill, an injection or an infusion
  • How often you take it, and the dates of your last and next dose
  • When you started
  • Whether it was prescribed for osteoporosis or as part of cancer treatment
  • Any drug of this kind you took in the past, since the ADA notes that stopping a bisphosphonate may not eliminate the risk
  • Your other medications, especially corticosteroids
  • The name and phone number of the prescribing physician

AAOMS notes that your physicians can coordinate with an oral surgeon to provide personalized advice. The dental implant consultation guide lists what else to bring.

How the plan may changeLink to this section: How the plan may change

Getting the mouth healthy first. The ADA describes an oral health program of sound hygiene practices and regular dental care as possibly the optimal approach for lowering risk. In practice that means treating gum disease and staying current with cleanings before surgery is scheduled. Beachside Dental Group in Huntington Beach has a page on gum disease treatment, and Marina Dentistry covers teeth cleaning in Marina del Rey.

Checking a denture that no longer fits. Cleveland Clinic lists wearing dentures as a risk factor, especially if they do not fit well. If you wear a denture that has become loose, have it looked at. Rio Hondo Dental, the affiliated office in Downey, has a page on denture repair and relines.

Weighing the amount of surgery. Extractions and bone grafts are jaw surgery too. Ask whether your plan includes them, and what the alternatives to implants would be.

If the drug is part of cancer treatmentLink to this section: If the drug is part of cancer treatment

The ADA's figures put the risk for people on IV bisphosphonates for cancer in the bone far above the risk for people on oral osteoporosis drugs. Cleveland Clinic notes that a complete dental assessment before starting these medicines for cancer can greatly reduce the risk.

Whether elective surgery such as an implant is advisable at all in that situation is a question for your oncology team and an oral and maxillofacial surgeon, and the answer may be no.

After surgery: what to reportLink to this section: After surgery: what to report

Tell the treating dentist promptly about an area that is not closing over, bone you can see or feel, jaw pain, a loose tooth, mouth sores, swelling or any sign of infection. Cleveland Clinic notes that some people have no symptoms at first, so keep every follow-up visit.

Cleveland Clinic says early detection and treatment can keep the condition from getting worse. The dental implant recovery guide describes ordinary healing, so you have something to compare against.

What to ask at your consultationLink to this section: What to ask at your consultation

  • Given the drug, the dose and how long I have taken it, how do you rate my risk?
  • Will you contact my prescribing physician before planning surgery?
  • Is there gum disease or another problem that should be treated first?
  • Does my plan involve extractions or bone grafting, and is there a way to do less?
  • What would you recommend if implants are not advisable for me?
  • What should I watch for afterward, and how often will you check the site?

Next stepLink to this section: Next step

Bring your medication details and your prescriber's contact information to the first visit. Request a consultation at a Huntington Beach office, and read the dental implant candidates guide for the other health factors reviewed at the same appointment.

Quick answers

Can I get dental implants if I take a bisphosphonate for osteoporosis?

Often, yes. The American Dental Association states that antiresorptive therapy does not appear to be a contraindication for dental implant placement, while noting that larger and longer-term studies are needed. A dentist needs your full medication history, and will usually coordinate with your prescriber, before saying whether implants suit you.

Should I stop my osteoporosis medication before implant surgery?

Not on your own. The ADA states there is insufficient evidence to recommend a drug holiday for osteoporosis patients to prevent jaw problems, that stopping a bisphosphonate may not eliminate the risk, and that stopping may harm the treatment of low bone mass. Any change is for your prescriber to decide with the dentist.

What is medication-related osteonecrosis of the jaw?

Cleveland Clinic describes osteonecrosis of the jaw as a rare but serious condition in which bone cells in the jawbone die. The most obvious sign is an area of exposed jawbone that does not heal. It tends to follow dental procedures such as an extraction, an implant or a bone graft.

How common is the jaw problem for people on osteoporosis drugs?

The ADA states that the incidence is generally considered to be between 0.001% and 0.01% in patients taking oral bisphosphonates for osteoporosis, compared with between 1% and 10% of patients taking IV bisphosphonates for cancer that has spread to bone. It also cites an expert panel estimate of approximately 0.10% as the highest reliable figure for osteoporosis regimens.

Does denosumab carry the same concern as bisphosphonates?

The ADA names denosumab, along with bisphosphonates and romosozumab, among the drugs associated with the condition. It notes the osteoporosis dose is a 60-mg injection every 6 months, against 120 mg every 4 weeks for cancer-related uses. Tell the dentist the dates of your last and next injection.

Sources

  1. American Dental Association — Osteoporosis Medications and Medication-Related Osteonecrosis of the Jaw
  2. Cleveland Clinic — Osteonecrosis of the Jaw (ONJ)
  3. American Association of Oral and Maxillofacial Surgeons (MyOMS) — MRONJ: Risk Factors, Treatments and Concerns

This article is general dental education, not personal medical advice — diagnosis and treatment recommendations always require an examination at an affiliated office.

Have a question this article didn't answer?

Bring it to a consultation at an affiliated Huntington Beach office — exam, imaging, and a written plan, with no obligation.

Results update as you type. Use the down arrow to move into the results, then Enter to open one. Press Escape to close.

See all results on the search pageOr call (714) 842-6151